Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples

OBJECTIVES: In order to cope with the rapid spread of the COVID-19 pandemic, we introduced on our in-house high-throughput molecular diagnostic platform (MDx Platform) a real-time reverse transcriptase PCR (RT-PCR) to detect the SARS-CoV-2 from any clinical specimens. The aim of this study was to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Opota, Onya, Brouillet, René, Greub, Gilbert, Jaton, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Priority
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657383/
https://www.ncbi.nlm.nih.gov/pubmed/33030200
http://dx.doi.org/10.1093/femspd/ftaa061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657383/
https://www.ncbi.nlm.nih.gov/pubmed/33030200
http://dx.doi.org/10.1093/femspd/ftaa061

Ejemplares similares